688212 澳华内镜
已收盘 08-13 15:00:01
资讯
新帖
简况
8月12日澳华内镜涨6.68%，圆信永丰医药健康A基金重仓该股
证券之星 · 08-12 16:32
8月12日澳华内镜涨6.68%，圆信永丰医药健康A基金重仓该股
澳华内镜：ERCP手术机器人已进入创新医疗器械特别审查程序
证券之星 · 08-10
澳华内镜：ERCP手术机器人已进入创新医疗器械特别审查程序
澳华内镜获得发明专利授权：“力反馈调节装置”
证券之星 · 08-05
澳华内镜获得发明专利授权：“力反馈调节装置”
澳华内镜新注册《澳华AQ-400系列电子内窥镜系统软件V1.0》项目的软件著作权
证券之星 · 08-05
澳华内镜新注册《澳华AQ-400系列电子内窥镜系统软件V1.0》项目的软件著作权
澳华内镜新注册《澳华AQ-200系列电子内窥镜系统软件V1.1》等2个项目的软件著作权
证券之星 · 08-01
澳华内镜新注册《澳华AQ-200系列电子内窥镜系统软件V1.1》等2个项目的软件著作权
股市必读：澳华内镜（688212）7月22日董秘有最新回复
证券之星 · 07-23
股市必读：澳华内镜（688212）7月22日董秘有最新回复
澳华内镜创历史新低
格隆汇 · 07-22
澳华内镜创历史新低
7月17日澳华内镜跌7.46%，富国精准医疗混合A基金重仓该股
证券之星 · 07-17
7月17日澳华内镜跌7.46%，富国精准医疗混合A基金重仓该股
澳华内镜新注册《澳华电子内窥镜系统软件（AQ-120系列）V1.1》项目的软件著作权
证券之星 · 07-14
澳华内镜新注册《澳华电子内窥镜系统软件（AQ-120系列）V1.1》项目的软件著作权
澳华内镜新注册《澳华AQ-300系列电子内窥镜系统软件V1.1》等2个项目的软件著作权
证券之星 · 07-11
澳华内镜新注册《澳华AQ-300系列电子内窥镜系统软件V1.1》等2个项目的软件著作权
澳华内镜（688212）披露补缴税款公告，7月1日股价上涨1.9%
证券之星 · 07-01
澳华内镜（688212）披露补缴税款公告，7月1日股价上涨1.9%
澳华内镜（688212）新增【机器人】概念
证券之星 · 06-23
澳华内镜（688212）新增【机器人】概念
股市必读：澳华内镜（688212）6月18日披露最新机构调研信息
证券之星 · 06-22
股市必读：澳华内镜（688212）6月18日披露最新机构调研信息
【机构调研记录】华宝基金调研澳华内镜
证券之星 · 06-19
【机构调研记录】华宝基金调研澳华内镜
每周股票复盘：澳华内镜（688212）变更主要办公地址
证券之星 · 06-07
每周股票复盘：澳华内镜（688212）变更主要办公地址
澳华内镜（688212）披露关于变更主要办公地址的公告，6月2日股价上涨0.55%
证券之星 · 06-02
澳华内镜（688212）披露关于变更主要办公地址的公告，6月2日股价上涨0.55%
澳华内镜：澳小宝消化内镜辅助质控软件可兼容公司上消化道和下消化道电子内窥镜
证券之星 · 06-01
澳华内镜：澳小宝消化内镜辅助质控软件可兼容公司上消化道和下消化道电子内窥镜
股市必读：澳华内镜（688212）今年截至5月28日累计跌幅已超25%
证券之星 · 05-29
股市必读：澳华内镜（688212）今年截至5月28日累计跌幅已超25%
澳华内镜（688212）披露2025年年度股东会决议公告，5月25日股价下跌1.21%
证券之星 · 05-25
澳华内镜（688212）披露2025年年度股东会决议公告，5月25日股价下跌1.21%
每周股票复盘：澳华内镜（688212）股东会多项议案获通过
证券之星 · 05-24
每周股票复盘：澳华内镜（688212）股东会多项议案获通过
加载更多
公司概况
公司名称：
上海澳华内镜股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-11-15
主营业务：
上海澳华内镜股份有限公司的主营业务是电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。公司的主要产品是电子消化内镜、耳鼻喉镜、支气管镜、内镜诊疗耗材。公司是国家级专精特新“小巨人”企业。
发行价格：
22.50
{"stockData":{"symbol":"688212","market":"SH","secType":"STK","nameCN":"澳华内镜","latestPrice":31.15,"timestamp":1786604401000,"preClose":31.8,"halted":0,"volume":6335655,"delay":0,"changeRate":-0.0204,"floatShares":135000000,"shares":135000000,"eps":0.1175,"marketStatus":"已收盘","change":-0.65,"latestTime":"08-13 15:00:01","open":31.42,"high":32.28,"low":30.3,"amount":198000000,"amplitude":0.0623,"askPrice":31.17,"askSize":25,"bidPrice":31.15,"bidSize":6,"shortable":0,"etf":0,"ttmEps":0.1175,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786671000000},"marketStatusCode":5,"adr":0,"adjPreClose":31.8,"symbolType":"stock_kcb","openAndCloseTimeList":[[1786584600000,1786591800000],[1786597200000,1786604400000]],"highLimit":34.98,"lowLimit":28.62,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":134665250,"isCdr":false,"pbRate":3.26,"roa":"--","peRate":265.106383,"roe":"--","epsLYR":0.09,"committee":0.35865,"marketValue":4195000000,"turnoverRate":0.047,"status":1,"afterMarket":{"amount":0,"volume":0,"close":31.15,"buyVolume":1000,"sellVolume":0,"time":1786606437746,"indexStatus":"已收盘 08-13 15:30:00","preClose":31.8},"floatMarketCap":4195000000},"requestUrl":"/m/hq/s/688212","defaultTab":"news","newsList":[{"id":"2658920380","title":"8月12日澳华内镜涨6.68%，圆信永丰医药健康A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658920380","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658920380?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:32","pubTimestamp":1786523551,"startTime":"0","endTime":"0","summary":"证券之星消息，8月12日澳华内镜涨6.68%，收盘报31.8元，换手率6.42%，成交量8.64万手，成交额2.73亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共16家，其中持有数量最多的公募基金为圆信永丰基金的圆信永丰医药健康A。圆信永丰医药健康A目前规模为2.27亿元，最新净值1.9464，较上一交易日上涨0.26%，近一年下跌2.51%。圆信永丰医药健康A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200027622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1515","688212","BK1574","BK1161","150219","09939","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658989071","title":"澳华内镜：ERCP手术机器人已进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2658989071","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658989071?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:39","pubTimestamp":1786351149,"startTime":"0","endTime":"0","summary":"证券之星消息，澳华内镜(688212)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，请问贵司的手术机器人是否为创新医疗器械？目前该手术机器人享受何种政策？这种政策是否可以和创新药的政策相比？澳华内镜回复：您好，ERCP手术机器人已进入创新医疗器械特别审查程序，在注册申报时将获得优先办理的权益，可有效缩短产品注册周期，加快产品的上市速度。详情见2026年5月8日公司对外披露的公司公告。感谢您对澳华内镜的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000020584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251","09996","BK1574","BK1583","159883","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657156966","title":"澳华内镜获得发明专利授权：“力反馈调节装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2657156966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657156966?lang=zh_cn&edition=full","pubTime":"2026-08-05 03:52","pubTimestamp":1785873175,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示澳华内镜新获得一项发明专利授权，专利名为“力反馈调节装置”，专利申请号为CN202111659225.4，授权日为2026年8月4日。本发明提供的力反馈调节装置，通过对反馈力合理调节，可使内窥镜在人体内活动时易于掌控，同时，避免了内窥镜在人体内活动时力度过大，导致人体出现不适的反应。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500005906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657879565","title":"澳华内镜新注册《澳华AQ-400系列电子内窥镜系统软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2657879565","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657879565?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:29","pubTimestamp":1785868153,"startTime":"0","endTime":"0","summary":"证券之星消息，近日澳华内镜（688212）新注册了《澳华AQ-400系列电子内窥镜系统软件V1.0》项目的软件著作权。今年以来澳华内镜新注册软件著作权6个。结合公司2025年年报财务数据，2025年公司在研发方面投入了1.47亿元，同比减10.14%。通过天眼查大数据分析，上海澳华内镜股份有限公司共对外投资了9家企业，参与招投标项目978次；财产线索方面有商标信息35条，专利信息294条，著作权信息19条；此外企业还拥有行政许可466个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","159180","688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656395674","title":"澳华内镜新注册《澳华AQ-200系列电子内窥镜系统软件V1.1》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2656395674","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656395674?lang=zh_cn&edition=full","pubTime":"2026-08-01 02:20","pubTimestamp":1785522023,"startTime":"0","endTime":"0","summary":"证券之星消息，近日澳华内镜（688212）新注册了2个项目的软件著作权，包括《澳华AQ-200系列电子内窥镜系统软件V1.1》、《澳华AQ-100系列电子内窥镜系统软件V1.1》等。今年以来澳华内镜新注册软件著作权5个。结合公司2025年年报财务数据，2025年公司在研发方面投入了1.47亿元，同比减10.14%。通过天眼查大数据分析，上海澳华内镜股份有限公司共对外投资了9家企业，参与招投标项目978次；财产线索方面有商标信息35条，专利信息294条，著作权信息19条；此外企业还拥有行政许可466个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080100000570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653762984","title":"股市必读：澳华内镜（688212）7月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653762984","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653762984?lang=zh_cn&edition=full","pubTime":"2026-07-23 01:24","pubTimestamp":1784741054,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，澳华内镜报收于25.38元，下跌2.23%，换手率2.0%，成交量2.7万手，成交额6912.88万元。董秘最新回复投资者： 董秘您好，我是一名财经博主，我注意到：贵公司过去五年加总的实际所得税率位于行业最低10%。当日关注点交易信息汇总：7月22日主力资金净流出610.91万元，游资资金净流入478.71万元，散户资金净流入132.21万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300001410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653673478","title":"澳华内镜创历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2653673478","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653673478?lang=zh_cn&edition=full","pubTime":"2026-07-22 14:15","pubTimestamp":1784700939,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0251","688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652152405","title":"7月17日澳华内镜跌7.46%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652152405","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652152405?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:24","pubTimestamp":1784276674,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日澳华内镜跌7.46%，收盘报26.8元，换手率3.48%，成交量4.68万手，成交额1.28亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共22家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为31.86亿元，最新净值3.7269，较上一交易日上涨0.34%，近一年上涨10.42%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700029753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651016146","title":"澳华内镜新注册《澳华电子内窥镜系统软件（AQ-120系列）V1.1》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2651016146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651016146?lang=zh_cn&edition=full","pubTime":"2026-07-14 02:24","pubTimestamp":1783967053,"startTime":"0","endTime":"0","summary":"证券之星消息，近日澳华内镜（688212）新注册了《澳华电子内窥镜系统软件（AQ-120系列）V1.1》项目的软件著作权。今年以来澳华内镜新注册软件著作权3个。结合公司2025年年报财务数据，2025年公司在研发方面投入了1.47亿元，同比减10.14%。通过天眼查大数据分析，上海澳华内镜股份有限公司共对外投资了9家企业，参与招投标项目970次；财产线索方面有商标信息35条，专利信息293条，著作权信息16条；此外企业还拥有行政许可466个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400001722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650342551","title":"澳华内镜新注册《澳华AQ-300系列电子内窥镜系统软件V1.1》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2650342551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650342551?lang=zh_cn&edition=full","pubTime":"2026-07-11 02:33","pubTimestamp":1783708389,"startTime":"0","endTime":"0","summary":"证券之星消息，近日澳华内镜（688212）新注册了2个项目的软件著作权，包括《澳华AQ-300系列电子内窥镜系统软件V1.1》、《澳华电子内窥镜系统软件（OR系列）V1.1》等。今年以来澳华内镜新注册软件著作权2个。结合公司2025年年报财务数据，2025年公司在研发方面投入了1.47亿元，同比减10.14%。通过天眼查大数据分析，上海澳华内镜股份有限公司共对外投资了9家企业，参与招投标项目970次；财产线索方面有商标信息35条，专利信息293条，著作权信息16条；此外企业还拥有行政许可466个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071100000486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","BK0251","688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648511190","title":"澳华内镜（688212）披露补缴税款公告，7月1日股价上涨1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648511190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648511190?lang=zh_cn&edition=full","pubTime":"2026-07-01 17:48","pubTimestamp":1782899314,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，澳华内镜报收于29.96元，较前一交易日上涨1.9%，最新总市值为40.35亿元。该股当日开盘29.11元，最高30.35元，最低28.71元，成交额达6027.8万元，换手率为1.51%。公司于近日披露《关于补缴税款的公告》。公告显示，上海澳华内镜股份有限公司根据税务部门要求开展涉税事项自查，需补缴税款及滞纳金合计人民币1,217.30万元。截至公告披露日，相关款项已缴纳完毕，不涉及行政处罚。本次补缴不影响公司正常生产经营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100034618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645836786","title":"澳华内镜（688212）新增【机器人】概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2645836786","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645836786?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:30","pubTimestamp":1782217824,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，6月23日澳华内镜新增概念。澳华内镜主营业务：电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。澳华内镜2026年一季报显示，一季度公司主营收入1.38亿元，同比上升11.13%；归母净利润-2443.33万元，同比上升15.14%；扣非净利润-2681.61万元，同比上升13.5%；负债率34.91%，投资收益1.09万元，财务费用335.83万元，毛利率71.63%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300039468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645301645","title":"股市必读：澳华内镜（688212）6月18日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2645301645","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645301645?lang=zh_cn&edition=full","pubTime":"2026-06-22 04:57","pubTimestamp":1782075427,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，澳华内镜报收于27.83元，上涨0.58%，换手率1.79%，成交量2.42万手，成交额6791.01万元。机构调研要点：AQ-400 3D超高清软镜系统于2025年6月获医疗器械注册证，9月线上发布，2025年Q4已实现销售与装机，处于市场导入阶段。2026年一季度毛利率同比提升5.27个百分点，主要系国内高毛利产品占比提升及境外收入占比下降共同影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200001671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644329010","title":"【机构调研记录】华宝基金调研澳华内镜","url":"https://stock-news.laohu8.com/highlight/detail?id=2644329010","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644329010?lang=zh_cn&edition=full","pubTime":"2026-06-19 08:01","pubTimestamp":1781827285,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及6月18日披露的机构调研信息，华宝基金近期对1家上市公司进行了调研，相关名单如下：1）澳华内镜 调研纪要：公司ERCP手术机器人已进入临床验证关键阶段，2025年Q4启动注册临床入组，研究成果被《Endoscopy》接收。该机器人临床需求刚性，目标覆盖三级及基层医院，市场空间可观。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061900004875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641127986","title":"每周股票复盘：澳华内镜（688212）变更主要办公地址","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641127986?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:30","pubTimestamp":1780770633,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，澳华内镜报收于29.8元，较上周的30.29元下跌1.62%。本周，澳华内镜6月1日盘中最高价报31.4元。澳华内镜当前最新总市值40.13亿元，在医疗器械板块市值排名83/129，在两市A股市值排名3824/5206。本周关注点公司公告汇总：澳华内镜因迁入新建总部大楼，变更主要办公地址至上海市闵行区瓶北路351号。具体联系信息为：办公及联系地址上海市闵行区瓶北路351号澳华内镜总部大厦，投资者联系电话021-54303731，投资者邮箱ir@aohua.com，公司网址www.aohua.com。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640148911","title":"澳华内镜（688212）披露关于变更主要办公地址的公告，6月2日股价上涨0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640148911","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640148911?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:48","pubTimestamp":1780393739,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，澳华内镜报收于30.88元，较前一交易日上涨0.55%，最新总市值为41.58亿元。该股当日开盘30.72元，最高31.4元，最低30.1元，成交额达5553.4万元，换手率为1.34%。近日，澳华内镜发布《关于变更主要办公地址的公告》。公告显示，公司因迁入新建总部大楼，变更主要办公地址：变更前为上海市闵行区光中路133弄66号，变更后为上海市闵行区瓶北路351号。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200035039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640303879","title":"澳华内镜：澳小宝消化内镜辅助质控软件可兼容公司上消化道和下消化道电子内窥镜","url":"https://stock-news.laohu8.com/highlight/detail?id=2640303879","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640303879?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:36","pubTimestamp":1780306588,"startTime":"0","endTime":"0","summary":"作为投资者我一直深信AI医疗软件与贵司硬件结合会极大提升诊疗效果，目前，院方反馈贵司AI软件与设备结合后的效果如何？公司澳小宝消化内镜辅助质控软件具有上消化道和下消化道辅助质控功能，可兼容公司上消化道和下消化道电子内窥镜。在AI辅助质控软件的助力下，医院可统计内镜检查用时、病变检出率、早癌检出率等数据，实现对内镜检查的量化和实时管理，减少病灶漏诊误诊的风险，提高内镜检查质量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100026675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639613486","title":"股市必读：澳华内镜（688212）今年截至5月28日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639613486","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639613486?lang=zh_cn&edition=full","pubTime":"2026-05-29 03:03","pubTimestamp":1779995035,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，澳华内镜报收于31.15元，下跌1.92%，换手率0.92%，成交量1.25万手，成交额3878.33万元。交易信息汇总股价提醒5月28日澳华内镜收盘报31.15元，跌1.92%，当日成交124.56万元。该股已连续9日下跌，当年累计跌幅27.44%。前10个交易日资金流向情况：主力资金累计净流入972.88万元，股价累计下跌14.25%；融资余额累计减少2355.05万元，融券余量累计减少200股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900003223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638353449","title":"澳华内镜（688212）披露2025年年度股东会决议公告，5月25日股价下跌1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638353449","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638353449?lang=zh_cn&edition=full","pubTime":"2026-05-25 18:13","pubTimestamp":1779703993,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，澳华内镜报收于33.58元，较前一交易日下跌1.21%，最新总市值为45.22亿元。该股当日开盘33.93元，最高34.38元，最低33.02元，成交额达4205.28万元，换手率为0.93%。近日，上海澳华内镜股份有限公司发布《2025年年度股东会决议公告》。公告显示，公司于2026年5月22日召开2025年年度股东会，会议由董事会召集，董事长顾小舟主持，采用现场与网络投票相结合方式召开。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500026002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637376901","title":"每周股票复盘：澳华内镜（688212）股东会多项议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2637376901","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637376901?lang=zh_cn&edition=full","pubTime":"2026-05-24 05:00","pubTimestamp":1779570042,"startTime":"0","endTime":"0","summary":"表决结果均为同意票超过出席会议股份的90%，各项议案均获通过。上海澳华内镜股份有限公司于2026年5月22日召开2025年年度股东会，会议由董事会召集，董事长顾小舟主持，采用现场与网络投票相结合方式召开。上海市通力律师事务所对本次会议进行了见证并出具法律意见书，认为会议召集、召开程序及表决结果合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786633949348,"stockEarnings":[{"period":"1week","weight":0.1844},{"period":"1month","weight":0.141},{"period":"3month","weight":-0.1159},{"period":"6month","weight":-0.2477},{"period":"1year","weight":-0.4154},{"period":"ytd","weight":-0.2725}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0332},{"period":"1year","weight":0.0766},{"period":"ytd","weight":-0.0056}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海澳华内镜股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"6675人(较上一季度增加14.47%)","perCapita":"20174股","listingDate":"2021-11-15","address":"上海市闵行区光中路133弄66号","registeredCapital":"13466万元","survey":" 上海澳华内镜股份有限公司的主营业务是电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。公司的主要产品是电子消化内镜、耳鼻喉镜、支气管镜、内镜诊疗耗材。公司是国家级专精特新“小巨人”企业。","listedPrice":22.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"澳华内镜(688212)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供澳华内镜(688212)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"澳华内镜,688212,澳华内镜股票,澳华内镜股票老虎,澳华内镜股票老虎国际,澳华内镜行情,澳华内镜股票行情,澳华内镜股价,澳华内镜股市,澳华内镜股票价格,澳华内镜股票交易,澳华内镜股票购买,澳华内镜股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"澳华内镜(688212)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供澳华内镜(688212)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}